Evopoint Biosciences
Evopoint Biosciences is a China-based biotechnology company running 6 late-stage cancer trials of XNW29016, XNW5004 and XNW28012 in peripheral T-cell lymphomas, follicular lymphoma and prostate cancer.
Overview
Evopoint Biosciences, based in Suzhou, China, is a biotechnology company. An innovation-focused pharmaceutical company (Chinese name Suzhou Innovent... registered as Suzhou Xinnuowei Pharmaceutical Technology Co.) developing small-molecule and antibody drugs for precision oncology and multi-drug resistant bacterial infections, using in-house small molecule, complex antibody (eMAB) and targeted protein degradation (eGLUE) platforms. On ClinicalTrials.gov it is the lead sponsor of 6 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing XNW29016, XNW5004 and XNW28012 in peripheral T-cell lymphomas, follicular lymphoma, prostate cancer, hodgkin lymphoma and pancreatic ductal adenocarcinoma. The largest, NCT06799637 (Study of XNW28012 in Subjects With Advanced Solid Tumours Who Failed Standard Treatments), plans to enrol 350 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 1/2 +1
- targets +2
- modalities +2
Similar pages
not linked directly; found by shared links- CompanyHaihe Biopharma
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Follicular lymphoma, Hodgkin lymphoma, Ovarian cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag ctgov-sponsor.
- CompanyBioInvent International
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Ovarian cancer and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma, Prostate cancer and the tag ctgov-sponsor.
- CompanyNuvation Bio
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma, Prostate cancer and the tag ctgov-sponsor.
- CompanyImmuneOncia Therapeutics
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma) and the tag ctgov-sponsor.
- CompanyInxMed (Shanghai)
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.